The results of a study published in the Journal of NeuroInterventional Surgery have shown that carotid stenting without post-dilation is safe and effective.
Brain surgeon Hrayr Shahinian (the Skull Base Institute, Los Angeles, USA), a pioneer in minimally invasive surgery, and NASA’s Jet Propulsion Laboratory in Pasadena, USA, have introduced the next generation of high-tech surgical instruments to remove tumours and treat other brain abnormalities.
New data has been reported supporting the clinical validation of MS Precise (DioGenix), a next-generation sequencing assay for the identification of patients with multiple sclerosis at first clinical presentation.
In final guidance, the National Institute for Health and Care Excellence (NICE) has recommended the use of Genzyme’s multiple sclerosis drug teriflunomide (also called Aubagio) for adults with relapsing-remitting multiple sclerosis.
In NHS guidance, the National Institute for Health and Care Excellence (NICE) has announced the results from clinical trials investigating a portable transcranial magnetic device for the treatment of migraine (SpringTMS, eNeura). The trials aimed to prevent or treat acute migraine among sufferers of pain, visual disturbance or sickness.
The study: “Examination of cognitive fatigue in multiple sclerosis using functional magnetic resonance imaging and diffusion tensor imaging” by Helen M Genova, research scientist in neuropsychology and neuroscience research at Kessler Foundation, USA, and others sheds light on the mechanisms of underlying cognitive fatigue in patients with multiple sclerosis.
Time is of the essence when treating head injuries to avoid potentially serious complications, including disability or death, says the National Institute for Health and Care Excellence (NICE). Its updated guidance on the issue emphasises the importance of early detection and prompt treatment for both children and adults who have suffered trauma to the head.
Vitamin D status appears to be associated with reduced disease activity in patients with multiple sclerosis and a slower rate of disease progression, according to a study published online first in JAMA Neurology by Alberto Ascherio, Harvard School of Public Health, Boston, USA, and colleagues.
The presence of a gene variant in people with mild cognitive impairment is associated with accelerated rates of brain atrophy, according to a new study published online in the journal Radiology.
Results of an internal study of 40 worldwide Visius surgical theatre hospital customers indicates that nearly 13,000 patients have been treated using intraoperative MRI (iMRI) since the first installation in 2005
Stryker and NeuroLogica have announced an exclusive partnership agreement in which Stryker will promote and sell NeuroLogica’s BodyTom portable full-body computed tomography (CT) scanner for the specialties of neurosurgery, spine surgery, orthopaedic surgery, and trauma surgery in conjunction with the Stryker NAV3i surgical navigation platform
A study from Australia, published online first in BMC Psychology, has confirmed the effectiveness a new test for Alzheimer’s disease. The test is said to detect cognitive decline in patients by scoring attention/reaction and learning/memory and comparing the scores to traditional cognitive impairment indicators
University Medical Center Hamburg-Eppendorf, Germany, is now offering the use of the EBS Next Wave brain stimulation device designed to expand the visual field of patients with impaired vision caused by optic nerve damage, it was announced by EBS Technologies.
The Society of NeuroInterventional Surgery (SNIS) on 9 January has launched a 2014 national tour that will bring together physicians and medical personnel across the USA involved in stroke care to address current stroke treatment and the value of neurointerventional therapy in optimal stroke care delivery.
The first patient was treated in the phase I/II NSI-566 stem cell trial to treat motor deficits from ischaemic stroke at BaYi Brain Hospital in Beijing, China, according to a press release.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos